Financials
- Market Capitalization 2.53 B
- Employee 13
- Founded 2006
- CEO Angelos M. Stergiou
- Website www.sellaslifesciences.com
- Headquarter Delaware, United States
- FIGI BBG000VC77H7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1837 | IMNM Immunome, Inc. - Common Stock | 22.28 USD | -1.37% | -9.98% | +23.57% | +159.98% | 2.52 B USD | ||
| 1845 | TRVI Trevi Therapeutics, Inc. - Common Stock | 17.61 USD | -1.68% | -8.52% | +20.04% | +156.71% | 2.50 B USD | ||
| 1860 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.45 USD | -2.98% | -12.26% | +3.96% | +8.00% | 2.40 B USD | ||
| 1873 | TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 55.17 USD | -1.68% | -21.07% | -11.20% | -16.49% | 2.37 B USD |
Frequently asked questions about SELLAS Life Sciences Group, Inc. - Common Stock
What is the SELLAS Life Sciences Group, Inc. - Common Stock stock price today?
The current price of SELLAS Life Sciences Group, Inc. - Common Stock (SLS) is 13.6. Over the past 24 hours, the stock has changed by +1.57%. Follow the SLS chart for real-time price dynamics.
What is the stock ticker of SELLAS Life Sciences Group, Inc. - Common Stock?
SELLAS Life Sciences Group, Inc. - Common Stock trades under the ticker SLS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is SELLAS Life Sciences Group, Inc. - Common Stock stock going up?
SLS has changed by -6.98% over the last week, +78.95% over the last month, and +608.33% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does SELLAS Life Sciences Group, Inc. - Common Stock release financial reports?
Yes. You can track SELLAS Life Sciences Group, Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was SELLAS Life Sciences Group, Inc. - Common Stock net income for the last quarter?
SELLAS Life Sciences Group, Inc. - Common Stock reported net income of -8.41 M for the last quarter. The previous quarter showed -7.66 M, which means net income changed by -9.78%.
How many employees does SELLAS Life Sciences Group, Inc. - Common Stock have?
As of the latest available data, SELLAS Life Sciences Group, Inc. - Common Stock has 13 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy SELLAS Life Sciences Group, Inc. - Common Stock stock?
You can buy SELLAS Life Sciences Group, Inc. - Common Stock (SLS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in SELLAS Life Sciences Group, Inc. - Common Stock stock?
Investing in SELLAS Life Sciences Group, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SLS chart and related analysis on metatrader.com as part of your research.